1. Home
  2. GTE vs ELDN Comparison

GTE vs ELDN Comparison

Compare GTE & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gran Tierra Energy Inc.

GTE

Gran Tierra Energy Inc.

HOLD

Current Price

$8.22

Market Cap

293.7M

Sector

Energy

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.95

Market Cap

300.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTE
ELDN
Founded
2003
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.7M
300.3M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
GTE
ELDN
Price
$8.22
$3.95
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
338.3K
1.1M
Earning Date
05-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.67
EPS
N/A
N/A
Revenue
$374,460,000.00
N/A
Revenue This Year
$1.39
N/A
Revenue Next Year
$2.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
41.99
N/A
52 Week Low
$3.09
$1.35
52 Week High
$9.74
$4.60

Technical Indicators

Market Signals
Indicator
GTE
ELDN
Relative Strength Index (RSI) 41.31 60.04
Support Level $7.30 $2.52
Resistance Level $9.69 $4.14
Average True Range (ATR) 0.48 0.22
MACD -0.14 -0.02
Stochastic Oscillator 6.54 70.55

Price Performance

Historical Comparison
GTE
ELDN

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. The majority of its revenue comes from operations in Colombia.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: